@cp-cellrepmed.bsky.social
@cp-cellrepmed.bsky.socialOnline now: Lipid-engineered antibody-based therapeutics target inflamed joints and lymph nodes to enhance rheumatoid arthritis treatment
@cp-cellrepmed.bsky.socialOnline now: Regional brain aging signatures predict mortality through neurovascular immune mechanisms
@cp-cellrepmed.bsky.socialOnline now: A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance
@cp-cellrepmed.bsky.socialOnline now: A translational pipeline for classification of variants of uncertain significance to support gene therapy clinical trial in OTOF-related deafness
@cp-cellrepmed.bsky.socialOnline now: Oral microbial nitrate metabolism is associated with lower prevalence of prediabetes
@cp-cellrepmed.bsky.socialOnline now: Fusion-loop-engineered Zika mRNA vaccine elicits convergent B cell immunodominance to uncouple protection from ADE in macaques
@cp-cellrepmed.bsky.socialOnline now: Disruption of the Nav1.8/Ankyrin-3 interaction in nociceptors reduces pathological pain-like behaviors in mice
@cp-cellrepmed.bsky.socialHave new research in organoids, NAMs or human tissue models?
Submit an abstract to #CPSOrganoidsNAMs27 for a chance to present your work in Bruges, Belgium, April 28–30, 2027
📅 Deadline: January 22, 2027
🔗 http://dlvr.it/TVpGYr
@CellPressEvents
@cp-cellrepmed.bsky.socialOnline now: Bridging innate and adaptive immunity: A bispecific SIRPαD1-αPCSK9 fusion protein reprograms macrophages for durable tumor clearance
@cp-cellrepmed.bsky.socialOnline now: From patient cells to patient therapy: Twenty years of iPSC-based translation in neurodegenerative disease
@cp-cellrepmed.bsky.socialOnline now: Multi-omics-driven personalized management of advanced HCC
@cp-cellrepmed.bsky.socialOnline now: Enhanced liver regeneration via targeted mRNA delivery for partial in vivo reprogramming
@cp-cellrepmed.bsky.socialOnline now: In vivo-edited CCR7+IL-7+ DCs reverse T cell exhaustion by promoting T memory stem cell differentiation
@cp-cellrepmed.bsky.socialOnline now: EZH2-dependent phenotypic plasticity reveals TTP-associated and mTORC1 therapeutic vulnerabilities in lethal prostate cancer
@cp-cellrepmed.bsky.socialOnline now: Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer
@cp-cellrepmed.bsky.socialOnline now: A multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics
@cp-cellrepmed.bsky.socialOnline now: Potently neutralizing and protective human monoclonal antibodies against the measles fusion protein trimer
@cp-cellrepmed.bsky.socialOnline now: Structural basis for broad orthopoxvirus neutralization by two antibodies targeting distinct L1R epitopes
@cp-cellrepmed.bsky.socialOnline now: Potentiating immunotherapy in “immune-cold” solid tumors through orchestrating T cell immunity via tumor-specific genetic engineering
@cp-cellrepmed.bsky.socialOnline now: Human iPSC models of myocardial infarction: From injury to repair and therapeutic discovery
